QUANTITATION OF ANTICEPHALIN ANTIBODIES IN A COMPUTER-ASSISTED ENZYME-LINKED-IMMUNOSORBENT-ASSAY (ELISA) - RELATION TO LUPUS ANTICOAGULANT

被引:17
作者
SLETNES, KE
KEIRUNG, G
WISLOFF, F
机构
[1] Haematological Research Laboratory, Ullevål Hospital, University of Oslo
关键词
antiphospholipid antibodies; APTT; ELISA; Lupus anticoagulant;
D O I
10.1016/0049-3848(90)90323-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lupus anticoagulants (LA) are IgG or IgM antibodies which prolong phospholipid-dependent coagulation tests. For the detection and quantitation of such antibodies, we have developed an ELISA with cephalin as the coating antigen. The sensitivity of this assay was compared to the activated partial thromboplastin time (APTT). LA was defined as ≥ 5 sec prolongation of the APTT with standard cephalin dilution, or ≥ 10 sec prolongation with a high cephalin dilution, on a 1:1 mixture of patient and control plasma. Plasma samples from 158 healthy individuals were tested for anticephalin anti-bodies. The 97.5 percentile was chosen as the upper reference limit and allocated a value of 1 ELISA unit. A "four-parameter logistic" model was used for trans-formation of the absorbances to ELISA units. Of 314 plasma samples referred for LA screening, positive results were found in 62 by both APTT and ELISA. Twenty-three samples were ELISA positive and APTT negative; this finding may be explained by greater sensitivity of the ELISA, which gave positive results in a four-fold greater dilution than the APTT. Prolongation of the APTT without antibody activity was found in 8 samples of which 2 had an inhibitor of factor VIII:C, the remaining 6 probably had true LA. In conclusion, our computer-assisted ELISA is a sensitive and reliable test method for quantitation of anticephalin antibodies. This assay has a high concordance with LA as detected with the APTT. © 1990.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 35 条
[1]  
ALVING BM, 1985, THROMB HAEMOSTASIS, V54, P709
[2]   THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - STRIKING ASSOCIATION WITH THE PRESENCE OF CIRCULATING LUPUS ANTICOAGULANT [J].
BOEY, ML ;
COLACO, CB ;
GHARAVI, AE ;
ELKON, KB ;
LOIZOU, S ;
HUGHES, GRV .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 287 (6398) :1021-1023
[3]  
BOWIE EJW, 1963, J LAB CLIN MED, V62, P416
[4]   THE DEMONSTRATION OF LUPUS ANTICOAGULANT BY AN ENZYME-LINKED IMMUNOADSORBENT ASSAY [J].
BRANCH, DW ;
ROTE, NS ;
SCOTT, JR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 39 (02) :298-307
[5]  
CONLEY CL, 1952, J CLIN INVEST, V31, P621
[6]  
DUDLEY RA, 1985, CLIN CHEM, V31, P1264
[7]  
DYBKAER R, 1987, Journal of Clinical Chemistry and Clinical Biochemistry, V25, P657
[8]  
ELIAS M, 1984, ARCH INTERN MED, V144, P510, DOI 10.1001/archinte.144.3.510
[9]   SENSITIVE TEST DEMONSTRATING LUPUS ANTICOAGULANT AND ITS BEHAVIORAL PATTERNS [J].
EXNER, T ;
RICKARD, KA ;
KRONENBERG, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (01) :143-151
[10]  
Feinstein D I, 1972, Prog Hemost Thromb, V1, P75